Literature DB >> 21514617

Cellular entry via an actin and clathrin-dependent route is required for Lv2 restriction of HIV-2.

I P Harrison1, A McKnight.   

Abstract

Lv2 is a human factor that restricts infection of some HIV-2 viruses after entry into particular target cells. HIV-2 MCR is highly susceptible to Lv2 whereas HIV-2 MCN is not. The block is after reverse transcription but prior to nuclear entry. The viral determinants for this restriction have been mapped to the HIV-2 envelope and the capsid genes. Our model of Lv2 restriction suggests that the route taken into a cell is important in determining whether a productive infection occurs. Here we characterised the infectious routes used by MCN and MCR using chemical compounds and molecular techniques to distinguish between potential pathways. Our results suggest that susceptible MCR can enter restrictive HeLa(CD4) cells via two pathways; a clathrin/AP2 mediated endocytic route that is sensitive to Lv2 restriction and an alternative, non-clathrin mediated route, which results in more efficient infection.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21514617     DOI: 10.1016/j.virol.2011.04.001

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  Productive entry of HIV-1 during cell-to-cell transmission via dynamin-dependent endocytosis.

Authors:  Richard D Sloan; Björn D Kuhl; Thibault Mesplède; Jan Münch; Daniel A Donahue; Mark A Wainberg
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

2.  RNA-Associated Early-Stage Antiviral Factor Is a Major Component of Lv2 Restriction.

Authors:  Kelly M Marno; Eithne O'Sullivan; Christopher E Jones; Julieta Díaz-Delfín; Claire Pardieu; Richard D Sloan; Áine McKnight
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

3.  Feline leukemia virus infection requires a post-receptor binding envelope-dependent cellular component.

Authors:  Naveen Hussain; Kelly R Thickett; Hong Na; Cherry Leung; Chetankumar S Tailor
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

Review 4.  HIV entry: a game of hide-and-fuse?

Authors:  Gregory B Melikyan
Journal:  Curr Opin Virol       Date:  2013-11-01       Impact factor: 7.090

5.  HIV-1 Accessory Protein Vpr Interacts with REAF/RPRD2 To Mitigate Its Antiviral Activity.

Authors:  Kelly M Marno; Rebecca Pike; Joseph M Gibbons; Wing-Yiu Jason Lee; Christopher E Jones; Babatunji W Ogunkolade; Claire Pardieu; Alexander Bryan; Rebecca Menhua Fu; Gary Warnes; Paul A Rowley; Richard D Sloan; Áine McKnight
Journal:  J Virol       Date:  2020-01-31       Impact factor: 5.103

6.  A whole genome screen for HIV restriction factors.

Authors:  Li Liu; Nidia M M Oliveira; Kelly M Cheney; Corinna Pade; Hanna Dreja; Ann-Marie H Bergin; Viola Borgdorff; David H Beach; Cleo L Bishop; Matthias T Dittmar; Aine McKnight
Journal:  Retrovirology       Date:  2011-11-14       Impact factor: 4.602

7.  Lv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIVMAC/SIVSM/HIV-2 Lineage Prior to Integration.

Authors:  Massimo Pizzato; Sean Matthew McCauley; Martha R Neagu; Thomas Pertel; Claudia Firrito; Serena Ziglio; Ann Dauphin; Madeleine Zufferey; Lionel Berthoux; Jeremy Luban
Journal:  PLoS Pathog       Date:  2015-07-16       Impact factor: 6.823

8.  Novel restriction factor RNA-associated early-stage anti-viral factor (REAF) inhibits human and simian immunodeficiency viruses.

Authors:  Kelly M Marno; Babatunji W Ogunkolade; Corinna Pade; Nidia M M Oliveira; Eithne O'Sullivan; Áine McKnight
Journal:  Retrovirology       Date:  2014-01-10       Impact factor: 4.602

9.  HIV-2 infects resting CD4+ T cells but not monocyte-derived dendritic cells.

Authors:  Lise Chauveau; Isabel Puigdomenech; Diana Ayinde; Ferdinand Roesch; Françoise Porrot; Daniela Bruni; Benoit Visseaux; Diane Descamps; Olivier Schwartz
Journal:  Retrovirology       Date:  2015-01-13       Impact factor: 4.602

10.  Cyclophilins and nucleoporins are required for infection mediated by capsids from circulating HIV-2 primary isolates.

Authors:  João I Mamede; Florence Damond; Ariel de Bernardo; Sophie Matheron; Diane Descamps; Jean-Luc Battini; Marc Sitbon; Valérie Courgnaud
Journal:  Sci Rep       Date:  2017-03-27       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.